GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLB Pharmaceutical Co Ltd (XKRX:047920) » Definitions » Net Margin %

HLB Pharmaceutical Co (XKRX:047920) Net Margin % : 6.60% (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is HLB Pharmaceutical Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. HLB Pharmaceutical Co's Net Income for the three months ended in Dec. 2024 was ₩2,184 Mil. HLB Pharmaceutical Co's Revenue for the three months ended in Dec. 2024 was ₩33,090 Mil. Therefore, HLB Pharmaceutical Co's net margin for the quarter that ended in Dec. 2024 was 6.60%.

The historical rank and industry rank for HLB Pharmaceutical Co's Net Margin % or its related term are showing as below:

XKRX:047920' s Net Margin % Range Over the Past 10 Years
Min: -184.47   Med: -13.82   Max: 2.84
Current: 1.47


XKRX:047920's Net Margin % is ranked worse than
59.38% of 975 companies
in the Drug Manufacturers industry
Industry Median: 4.6 vs XKRX:047920: 1.47

HLB Pharmaceutical Co Net Margin % Historical Data

The historical data trend for HLB Pharmaceutical Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Pharmaceutical Co Net Margin % Chart

HLB Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -184.47 -21.04 -10.96 -14.29 1.47

HLB Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.39 -4.81 1.39 2.73 6.60

Competitive Comparison of HLB Pharmaceutical Co's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, HLB Pharmaceutical Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLB Pharmaceutical Co's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HLB Pharmaceutical Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where HLB Pharmaceutical Co's Net Margin % falls into.


;
;

HLB Pharmaceutical Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

HLB Pharmaceutical Co's Net Margin for the fiscal year that ended in Dec. 2024 is calculated as

Net Margin=Net Income (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=2019.778/137082.238
=1.47 %

HLB Pharmaceutical Co's Net Margin for the quarter that ended in Dec. 2024 is calculated as

Net Margin=Net Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=2184.344/33090.08
=6.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HLB Pharmaceutical Co  (XKRX:047920) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


HLB Pharmaceutical Co Net Margin % Related Terms

Thank you for viewing the detailed overview of HLB Pharmaceutical Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
67, Euiui-ro, Songpa-gu, MK Tower 9th Floor, Seoul, KOR
HLB Pharmaceutical Co Ltd is a research-oriented pharmaceutical company. It is engaged in developing medicines and drugs. Its products include skeletal muscle relaxant, pain relief drugs, blood pressure-lowering agents, local anaesthetics, digestive system drugs, antacids, vitamins, haemorrhoid solvents, insect repellents, peptic ulcer solvents, and other products.

HLB Pharmaceutical Co Headlines

No Headlines